Effect of Mashao Pingchuan Decoction on Traditional Chinese Medicine Symptoms and Quality of Life in Patients with Cold Asthma of Bronchial Asthma

Qin-jun YANG; Jia-bing TONG; Cheng YANG; Xin-heng WANG; Ming-xiang HAN; Ze-geng LI

doi:10.13422/j.cnki.syfjx.20210537

您当前的位置：

首页 >

文章列表页 >

Effect of Mashao Pingchuan Decoction on Traditional Chinese Medicine Symptoms and Quality of Life in Patients with Cold Asthma of Bronchial Asthma

Clinic | 更新时间：2021-02-09

- Effect of Mashao Pingchuan Decoction on Traditional Chinese Medicine Symptoms and Quality of Life in Patients with Cold Asthma of Bronchial Asthma
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 27, Issue 5, Pages: 84-90(2021)
- 作者机构：
  
  1.安徽中医药大学研究生院，合肥 230038
  2.安徽省教育厅重点实验室，合肥 230031
  3.安徽省中医药科学院中医呼吸病防治研究所，合肥 230031
  4.安徽中医药大学第一附属医院，合肥 230031
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20210537
  CLC： R2-0;R24;R256.12
- Published：05 March 2021，
  
  Published Online：12 January 2021，
  
  Received：10 October 2020，
- 稿件说明：
扫描看全文
杨勤军,童佳兵,杨程等.麻芍平喘汤对支气管哮喘冷哮证患者中医症状和生存质量的影响[J].中国实验方剂学杂志,2021,27(05):84-90.

YANG Qin-jun,TONG Jia-bing,YANG Cheng,et al.Effect of Mashao Pingchuan Decoction on Traditional Chinese Medicine Symptoms and Quality of Life in Patients with Cold Asthma of Bronchial Asthma[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(05):84-90.
杨勤军,童佳兵,杨程等.麻芍平喘汤对支气管哮喘冷哮证患者中医症状和生存质量的影响[J].中国实验方剂学杂志,2021,27(05):84-90. DOI： 10.13422/j.cnki.syfjx.20210537.

YANG Qin-jun,TONG Jia-bing,YANG Cheng,et al.Effect of Mashao Pingchuan Decoction on Traditional Chinese Medicine Symptoms and Quality of Life in Patients with Cold Asthma of Bronchial Asthma[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(05):84-90. DOI： 10.13422/j.cnki.syfjx.20210537.

摘要

目的

评价麻芍平喘汤对支气管哮喘冷哮证患者中医症状、生存质量及外周血嗜酸性粒细胞（Eos）和血清炎症因子白细胞介素-6（IL-6），白细胞介素-8（IL-8）的影响。

方法

选取2018年1月至2019年12月安徽省中医院呼吸门诊就诊的支气管哮喘冷哮证患者67例，随机分为对照组和观察组。对照组予布地奈德福莫特罗粉吸入剂吸入等基础治疗，观察组在对照组基础上予麻芍平喘汤口服。两组均连续干预7 d。观察记录两组哮喘患者一般情况、中医症状积分，哮喘控制问卷（ACQ）-7评分，Marks-哮喘生存质量问卷（Marks-AQLQ）评分；采用血细胞分析仪检测外周血Eos计数，酶联免疫吸附测定（ELISA）检测受试者血清IL-6，IL-8的含量。

结果

两组中医症状疗效总有效率均为100%（30/30），观察组疗效更明显（

=-2.169，

0.05）。治疗后，两组中医症状积分均较治疗前显著降低（

0.01），观察组喉中痰鸣、咯痰、咳嗽、畏寒肢冷证候积分组间均明显低于对照组（

0.05）。治疗后，两组ACQ-7评分，Marks-AQLQ评分均较治疗前显著降低（

0.01），观察组ACQ-7评分，Marks-AQLQ评分组间比较差异无统计学意义。治疗后，两组外周血Eos计数和血清IL-6，IL-8含量均较治疗前显著降低（

0.01），观察组外周血Eos计数和血清IL-6，IL-8含量均明显低于对照组（

0.05）。

结论

麻芍平喘汤联合布地奈德福莫特罗粉吸入治疗能有效提高哮喘冷哮证临床有效率，改善哮喘中医症状表现，ACQ-7评分，Marks-AQLQ评分，外周血Eos计数，血清炎症因子含量。

Abstract

Objective

To evaluate the effect of Mashao Pingchuan decoction on traditional Chinese medicine

（

TCM

）

symptoms， quality of life， peripheral blood eosinophils （Eos） and serum inflammatory factors interleukin-6 （IL-6） and interleukin-8 （IL-8） in patients with cold asthma syndrome of bronchial asthma.

Method

A total of 67 patients with cold asthma who attended the Respiratory Clinic of Anhui Provincial Hospital of TCM from January 2018 to December 2019 were selected and randomly divided into a control group and an observation group. The control group was given basic treatments such as budesonide formoterol powder inhalation， and the observation group was given Mashao Pingchuan decoction on the basis of the control group. Both groups intervened for 7 consecutive days. Observe and record the general condition， TCM symptom score， asthma control questionnaire （ACQ）-7 score， Marks-asthma quality of life questionnaire （Marks-AQLQ） score of the two groups of asthma patients， the peripheral blood Eos count was measured by hematology analyzer， and the serum IL-6 and IL-8 levels of the subjects were measured by enzyme-linked immunosorbent assay （ELISA）.

Result

The total effective rate of TCM symptoms in the two groups was 100%（30/30）， and the effect in the observation group was more obvious （

=-2.169，

0.05

）

. After treatment， the scores of TCM symptoms in the two groups were significantly lower than those before treatment （

0.01）. The scores of phlegm in the throat， expectoration， cough， and chills in the observation group were lower than those in the control group （

0.05）. After treatment， the ACQ-7 scores and Marks-AQLQ scores of the two groups were significantly lower than before treatment （

0.01）. There was no statistically significant difference between the observation group and the ACQ-7 scores and Marks-AQLQ scores. After treatment， the peripheral blood Eos counts and serum IL-6 and IL-8 levels in the two groups were significantly lower than before treatment （

0.01）. Peripheral blood Eos count and serum IL-6 and IL-8 contents in observation group were lower than those in control group （

0.05）.

Conclusion

Mashao Pingchuan decoction combined with budesonide formoterol powder inhalation can effectively improve the clinical effectiveness of asthma （cold asthma）， improve the symptoms of asthma in TCM， ACQ-7 score， Marks-AQLQ score， peripheral blood Eos count， serum inflammatory factor content.

关键词

麻芍平喘汤支气管哮喘冷哮证疗效评价生存质量

Keywords

Mashao Pingchuan decoctionbronchial asthmacold asthmacurative effect evaluationquality of life

references

中华医学会.支气管哮喘基层合理用药指南［J］.中华全科医师杂志，2020，19（7）：572-581.

REDDEL H K，BATEMAN E D，BECKER A，et al.A summary of the new GINA strategy：a roadmap to asthma control［J］.Eur Resp J，2015，46（3）：622-639.

贾琳，武蕾，李博林，等.加味消风散治疗支气管哮喘风哮证的疗效观察及对炎症因子的影响［J］.中国实验方剂学杂志，2019，25（4）：70-74.

HUANG K，YANG T，XU J，et al.Prevalence，risk factors，and management of asthma in China：a national cross-sectional study［J］.Lancet，2019，394（10196）：407-418.

徐增梅.哮病中医证候分布特点及麻芍平喘汤对哮喘大鼠模型气道重塑的干预研究［D］.合肥：安徽中医药大学，2015.

杨勤军，王心恒，杨程，等.麻芍平喘汤对哮喘大鼠气道重塑和气道炎症及肺组织TGF-β1、MUC5AC蛋白表达的影响［J］.中药药理与临床，2020，36（5）：154-159.

徐增梅，丁伟伟，李泽庚.麻芍平喘汤对哮喘模型大鼠气道重塑的干预作用［J］.中医药导报，2020，26（5）：23-26.

沈华浩.支气管哮喘防治指南（2016年版）［J］.中华结核和呼吸杂志，2016，39（9）：675-697.

晁恩祥，孙增涛，刘恩顺.支气管哮喘中医诊疗专家共识（2012）［J］.中医杂志，2013，54（7）：627-629.

张君成.射干平喘汤治疗冷哮型哮喘的临床观察［D］.哈尔滨：黑龙江省中医药科学院，2019.

FERREIRA J，SILVEIRA P，FIGUEIREDO M M，et al.Validation of the portuguese version of the asthma quality of life questionnaire ［AQLQ-M］by marks［J］.Rev Port Pneumol，2005，11（4）：351-366.

中华人民共和国卫生部.中药新药临床研究指导原则［M］.北京：中国医药科技出版社，2002：60.

JUNIPER E F，O'BYRNE P M，GUYATT G H，et al.Development and validation of a questionnaire to measure asthma control［J］.Eur Res J，1999，14（4）：902-907.

范戈，柴茂山.从阳虚寒饮论治冷哮［J］.山东中医药大学学报，2017，41（3）：216-217，225.

陈炜，韩明向.韩明向教授运用温法治疗痰饮咳喘经验［J］.新中医，2014，46（6）：19-20.

徐增梅，丁伟伟，李泽庚.麻芍平喘汤对哮喘大鼠气道重塑及TGF-β1、PDGF-BB的影响［J］.天津中医药大学学报，2017，36（2）：123-127.

朱慧华，虞坚尔.从痰瘀论治儿童支气管哮喘机理初探［J］.上海中医药杂志，2006，40（11）：40-41.

史雅旭，戴曦，王丽娇，等.川芎嗪调节TGF-β/Smad信号通路对哮喘小鼠气道炎症和气道重塑的影响［J］.现代药物与临床，2019，34（1）：20-26.

陈星，姚德祎，卢云，等.三桔咳喘口服液治疗哮喘急性发作期痰浊阻肺证的临床观察［J］.中国实验方剂学杂志，2020，26（4）：114-119.

AKUTHOTA P，WANG H B，SPENCER L A，et al.Immunoregulatory roles of eosinophils：a new look at a familiar cell［J］.Clin Exp Allergy，2008，38（8）：1254-1263.

SHRIMANKER R，KEENE O，HYNES G，et al.Prognostic and predictive value of blood eosinophil count，fractional exhaled nitric oxide，and their combination in severe asthma：a post hoc analysis［J］.Am J Respir Crit Care Med，2019，200（10）：1308-1312.

黄海萍，吴俊，殷烨军.支气管哮喘患者血清IL-6、TNF-α、IgE检测的临床分析［J］.放射免疫学杂志，2010，23（1）：64-66.

SHISHIMOROV I，PERMINOV A，GORBUNOV V.P56-control of allergic inflammation and erythrocytes magnesium level in children with bronchial asthma［J］.Clin Transl All，2014，doi：10.1186/2045-7022-4-S1-P111http://dx.doi.org/10.1186/2045-7022-4-S1-P111.

BAINES K J，SIMPSON J L，BOWDEN N A，et al.Differential gene expression and cytokine production from neutrophils in asthma phenotypes［J］.Eur Respir J，2010，35（3）：522-531.

王宁群，姜良铎，李宗信.支气管哮喘相关生存质量研究进展［J］.中西医结合学报，2008，6（1）：93-97.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Yiqi Wenyang Huwei Decoction Regulates PI3K/Akt/mTOR Pathway to Treat Bronchial Asthma in Rats

Mashao Pingchuan Decoction Inhibites Autophagy in Airway Epithelial Cells Through PI3K/Akt/mTOR Signaling Pathway

Clinical Efficacy and Bone Turnover Markers of Buzhong Yiqitang in Treatment of Senile Osteoporotic Vertebral Compression Fracture After Operation Based on ''Spleen Governing Muscle''

Effect of Shufeng Tongluo Prescription on Eotaxin and CCR3 Protein Expression and ERK Phosphorylation Level of Asthma Mice

Mechanism of Cordyceps in Treating Bronchial Asthma and Chronic Renal Failure with Concept of “Same Treatment for Different Diseases” Based on Network Pharmacology and Molecular Docking Technology

Related Author

XIANG Shuangdi

CHENG Linhui

YU Qiangqiang

XUE Hanrong

REN Yanqun

WANG Xiaole

LIU Tong

ZHANG Lu

Related Institution

Affiliated Hospital of Jiangxi University of Chinese Medicine

Jiangxi University of Chinese Medicine

Anhui University of Chinese Medicine

Key Laboratory of Xin'an Medicine， Ministry of Education

Key Laboratory of Chinese Medicine for Prevention and Treatment of Major Diseases in Pulmonary System，Key Laboratory of Anhui Provincial Education Department

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰